JBird17 Posted - 1 day ago

$EDAP good volume this morning

JBird17 Posted - 4 days ago

$EDAP if I did my time zones correctly, Gil Dubernard will be presenting the latest Endometriosis data at SEUD 2024 on Friday, the 19th at 5:45 am CST. 2:45 Switzerland time. His words on LinkedIn were that he was presenting the latest data for Endometriosis. Hopefully a sneak peak into Phase 3!

InsightInvestsub Posted - 1 week ago

Daily Market Newsletter Ticker:$AI(C3.AI) Along with my picks.🚀 $EDAP & $VULNF lead with innovation & sustainability. $NEWP explores Bolivia's gold. Watch $VITFF & $AVD for growth. 📈 #Stocks #Investing https://open.substack.com/pub/insightinvestsub/p/daily-market-newsletter-tickeraic3ai?r=2brmn5&utm_campaign=post&utm_medium=web&showWelcomeOnShare=true

JBird17 Posted - 1 week ago

$EDAP lots of good buys today!!! Glad they did the F3 on a Friday after hours to let it digest and realize it’s truly nothing.

OpenOutcrier Posted - 1 week ago

$EDAP (-4.5% pre) Form F-3 EDAP TMS SA https://ooc.bz/l/29728

briefingcom Posted - 1 week ago

Gapping Down: $PERI -37.8% $EDAP -4.5% $PWFL -2.5%

JBird17 Posted - 1 week ago

$EDAP straight from Seeking Alpha… “this prospectus is not an offer to sell these securities” https://seekingalpha.com/news/4087691-edap-tms-files-for-125m-mixed-shelf-offering

jarnolaine Posted - 1 week ago

@DonCorleone77 $EDAP this filing is just a housekeeping item. Needed to be renewed after 3 years.

DonCorleone77 Posted - 2 weeks ago

$EDAP EDAP TMS files $125M mixed securities shelf

MCOPA Posted - 2 weeks ago

$EDAP bought 2000 more at 7.49 Monday......Wainwright knows something....personally, I have not been posting much but 19 is going to be a light call!

JBird17 Posted - 03/29/24

$EDAP

JBird17 Posted - 03/28/24

$EDAP very positive price action today following the earnings report!

Stocksrunner Posted - 03/27/24

🚀📊 Earnings Alert! Keep an eye on: $ALT Missing EPS but watch for potential rebound! $CLRB EPS miss, but what's next for Cellectar Biosciences? $EDAP Mixed results, but beating revenue expectations! 📈💰 Stay tuned for potential market impacts! 📉📈

lecorb Posted - 03/27/24

$EDAP Edap TMS Q4 EPS $(0.15) Misses $(0.05) Estimate, Sales $21.30M Beat $19.66M Estimate 7:02 am ET March 27, 2024 (Benzinga) Edap TMS (NASDAQ:EDAP) reported quarterly losses of $(0.15) per share which missed the analyst consensus estimate of $(0.05) by 200 percent. This is a 7.14 percent decrease over losses of $(0.14) per share from the same period last year. The company reported quarterly sales of $21.30 million which beat the analyst consensus estimate of $19.66 million by 8.34 percent. This is a 31.55 percent increase over sales of $16.19 million the same period last year.

epsguid Posted - 03/27/24

$EDAP reported a loss of $0.15, consensus was ($0.02) via @eWhispers #epsmiss http://eps.sh/d/edap

DonCorleone77 Posted - 03/27/24

$EDAP 2 of 2 - EDAP TMS reports Q4 EPS (15c), consensus (5c) ....which we anticipate will provide further momentum for our business. "Looking ahead, I believe 2024 is shaping up to be another strong year for EDAP. We anticipate continued growth and adoption of Focal One among urologists, further establishing EDAP as the leading company in therapeutic robotic HIFU applications for prostate cancer. I'm also excited about the opportunities for our pipeline, as we recently announced the FDA's granting of Breakthrough Device designation for Focal One for the treatment of deep infiltrating endometriosis. With enrollment in our Phase 3 study recently completed, we expect our rectal endometriosis program to gain visibility in 2024, as we seek to address a significant unmet need in women's health with Focal One robotic HIFU therapy."

DonCorleone77 Posted - 03/27/24

$EDAP 1 of 2 - EDAP TMS reports Q4 EPS (15c), consensus (5c) Reports Q4 revenue $21.3M, consensus $19.66M. "We are pleased to report strong revenue and system placements in the fourth quarter and full-year 2023, reflecting growing demand for Focal One and ExactVu," said Ryan Rhodes, Chief Executive Officer of EDAP TMS. "Focal One's best-in-class robotic HIFU platform, attractive reimbursement, and the continued investments we are making in our regional clinical teams are all helping to drive demand for our technology among both academic and community hospitals. The continued robust growth in U.S. Focal One HIFU procedures also speaks to the growing number of urologists who recognize the value of robotic HIFU in the management of prostate cancer. By providing a non-invasive, non-surgical, and radiation-free treatment approach with excellent oncologic outcomes, we are seeing growing patient awareness of the Focal One treatment option....

Stock_Titan Posted - 03/27/24

$EDAP EDAP Reports Fourth Quarter and Full-Year 2023 Financial Results https://www.stocktitan.net/news/EDAP/edap-reports-fourth-quarter-and-full-year-2023-financial-so0tv1slar6l.html

JBird17 Posted - 03/26/24

$EDAP earnings release tomorrow at 5:00 am CT. Any estimates?

JBird17 Posted - 1 month ago

$EDAP Oppenheimer presentation starting now. Link can be found on press release

Stock_Titan Posted - 1 month ago

$EDAP EDAP to Announce Fourth Quarter and Full-Year 2023 Financial Results on March 27, 2024 https://www.stocktitan.net/news/EDAP/edap-to-announce-fourth-quarter-and-full-year-2023-financial-results-ornu05any40l.html

JBird17 Posted - 1 month ago

$EDAP according to Gol Dubernard on LinkedIn, the latest endometriosis data will be shared April 19 at SEUD2024. https://www.linkedin.com/posts/society-of-endometriosis-and-uterine-disorders_seud2024-gynecology-endometriosis-activity-7166086894710169601-EH9j

Stock_Titan Posted - 1 month ago

$EDAP EDAP to Present at the Oppenheimer 34th Annual Healthcare MedTech & Services Conference https://www.stocktitan.net/news/EDAP/edap-to-present-at-the-oppenheimer-34th-annual-healthcare-med-tech-4pebctfftes7.html

JBird17 Posted - 1 month ago

$EDAP decent after hours volume compared to the normal. We should break $8 tomorrow.

jlonards Posted - 1 month ago

$EDAP should be trading $15+

Stocksrunner Posted - 1 month ago

🚀 Today's Top Gainers in the headlines 📈: $M - Macys sees a $1 billion increase in takeover bid to $6.6 billion. $ETNB - Akero Therapeutics and 89bio surge 27% on promising liver disease treatment. $EDAP - FDA grants Breakthrough Device status to EDAP TMS for endometriosis treatment. Stay tuned for market moves! 💹

JBird17 Posted - 1 month ago

$EDAP here comes some volume!!! Great unexpected news today!

ChicagoGuy30 Posted - 1 month ago

Biotech / medical movers $Bysi up 13% on fda anticipation - this one is a $3 stock here in short term imo $Edap focal one BTD by the fda $Lly continues to crush

tradingtwenty Posted - 1 month ago

$EDAP has trended 10 times in the past 24 hours (based on 5 minute intervals). Latest article on Mar 04, 2024 07:00 AM: EDAP Announces FDA Breakthrough Device Designation for Focal One® in the Treatment of Deep Infiltrating Rectal Endometriosis Link: https://tradingtwenty.com/news/380848/edap-announces-fda-breakthrough-device-designation-for-focal-one-in-the-treatment-of-deep-infiltrating-rectal-endometriosis

RAPIDTRADX Posted - 1 month ago

$EDAP 👀